ARENTFOX SCHIFF LLP

Lobbying for PINNACLE BIOLOGICS, INC. · Developer of complex critical care therapies for cancers

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Illinois · House · Senate · $10,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Medicare/Medicaid

Calendar Year 2026 Hospital Outpatient Prospective Payment System proposed rule regarding Medicare coverage for a Pinnacle biologic product

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.